Abdel Razek, AA, Alvarez, H, Bagg, S, Refaat, S, Castillo, M. Imaging spectrum of CNS vasculitis. Radiographics. 2014;34(4): 873–894.CrossRefGoogle ScholarPubMed

Salvarani, C, Brown, RD Jr, Calamia, KT, et al. Primary central nervous system vasculitis: Analysis of 101 patients. Ann Neurol. 2007;62(5): 442–451.CrossRefGoogle ScholarPubMed

Moore, P. Neurology of vasculitides and connective tissue diseases. J Neurol Neurosurg Psychiatry. 1998;65: 10–22.CrossRefGoogle ScholarPubMed

Salvarani, C, Brown, RD Jr, Hunder, GG. Adult primary central nervous system vasculitis. Lancet. 2012;380(9843): 767–777.CrossRefGoogle ScholarPubMed

Calabrese, LH, Duna, GF, Lie, JT. Vasculitis in the central nervous system. Arthritis Rheum. 1997;40(7): 1189–1201.3.0.CO;2-4>CrossRefGoogle ScholarPubMed

Duna, GF, Calabrese, LH. Limitations of invasive modalities in the diagnosis of primary angiitis of the central nervous system. J Rheumatol. 1995;22(4): 662–667.Google ScholarPubMed

Garg, A. Vascular brain pathologies. Neuroimaging Clin N Am. 2011;21(4): 897–ix.CrossRefGoogle ScholarPubMed

Poels, MM, Ikram, MA, Vernooij, MW. Improved MR imaging detection of cerebral microbleeds more accurately identifies persons with vasculopathy. Am J Neuroradiol. 2012;33(8): 1553–1556.CrossRefGoogle ScholarPubMed

Berger, JR, Wei, T, Wilson, D. Idiopathic granulomatous angiitis of the CNS manifesting as diffuse white matter disease. Neurology. 1998;51: 1774–1775.CrossRefGoogle ScholarPubMed

Finelli, PF, Onykie, HC, Uphoff, DF. Idiopathic granulomatous angiitis of the CNS manifesting as diffuse white matter disease. Neurology. 1998;49: 1696–1699.CrossRefGoogle Scholar

Pomper, MG, Miller, TJ, Stone, JH, Tidmore, WC, Hellmann, DB. CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography. Am J Neuroradiol. 1999;20: 75–85.Google ScholarPubMed

Cloft, HJ, Phillips, CD, Dix, JE. Correlation of angiography and MR imaging in cerebral vasculitis. Acta Radiol. 1999;40: 83–87.CrossRefGoogle Scholar

Obusez, EC, Hui, F, Hajj-Ali, RA, et al. High-resolution MRI vessel wall imaging: spatial and temporal patterns of reversible cerebral vasoconstriction syndrome and central nervous system vasculitis. Am J Neuroradiol. 2014;35(8): 1527–1532.CrossRefGoogle ScholarPubMed

Zeiler, SR, Qiao, Y, Pardo, CA, Lim, M, Wasserman, BA. Vessel wall MRI for targeting biopsies of intracranial vasculitis. Am J Neuroradiol. 2018;39(11): 2034–2036.CrossRefGoogle ScholarPubMed

Eleftheriou, D, Cox, T, Saunders, D, et al. Investigation of childhood central nervous system vasculitis: Magnetic resonance angiography versus catheter cerebral angiography. Dev Med Child Neurol. 2010;52: 863–867.CrossRefGoogle ScholarPubMed

Calabrese, LH. Therapy of systemic vasculitis. Neurologic Clinics. 1997;15: 973–991.CrossRefGoogle ScholarPubMed

O’Brien, WT Sr, Vagal, AS, Cornelius, RS. Applications of computed tomography angiography (CTA) in neuroimaging. Semin Roentgenol. 2010;45(2): 107–115.CrossRefGoogle ScholarPubMed

Alhalabi, M, Moore, P. Serial angiography in isolated angiitis of the central nervous system. Neurology. 1994;44: 1221–1226.CrossRefGoogle ScholarPubMed

Rossi, CM, Di Comite, G. The clinical spectrum of the neurological involvement in vasculitides. J Neurol Sci. 2009;285(1–2): 13–21.CrossRefGoogle ScholarPubMed

Drier, A, Bonneville, F, Haroche, J, et al. Central nervous system involvement in systemic diseases: spectrum of MRI findings. J Neuroradiol. 2010;37(5): 255–267.CrossRefGoogle ScholarPubMed

Alis, D, Civcik, C, Erol, BC, et al. Flat-detector CT angiography in the evaluation of neuro-Behçet disease. Diagn Interv Imaging. 2017;98(11): 813–815.CrossRefGoogle ScholarPubMed

Parisi, JE, Moore, PM. The role of biopsy in vasculitis of the central nervous system. Semin Neurol. 1994; 4:341–348.CrossRefGoogle Scholar

Miller, DV, Salvarani, C, Hunder, GG, et al. Biopsy findings in primary angiitis of the central nervous system. Am J Surg Pathol. 2009;33(1): 35–43.CrossRefGoogle ScholarPubMed

Siva, A. Vasculitis of the nervous system. J Neurol. 2001;248(6): 451–468.CrossRefGoogle ScholarPubMed

Lie, JT. Primary (granulomatous) angiitis of the central nervous system: A clinicopathologic analysis of 15 new cases and a review of the literature. Hum Pathol. 1992;23(2): 164–171.CrossRefGoogle Scholar

Calabrese, LH, Mallek, JA. Primary angiitis of the central nervous system: Report of 8 new cases, review of the literature, and proposal for diagnostic criteria. Medicine. 1988;67: 20–39.CrossRefGoogle ScholarPubMed

Hajj-Ali, RA, Calabrese, LH. Primary angiitis of the central nervous system. Autoimmun Rev. 2013;12(4): 463–466.CrossRefGoogle ScholarPubMed

Salvarani, C, Brown, RD Jr, Calamia, KT, et al. Rapidly progressive primary central nervous system vasculitis. Rheumatology. 2011;50(2): 349–358.CrossRefGoogle ScholarPubMed

Salvarani, C, Brown, RD Jr, Calamia, KT, et al. Primary central nervous system vasculitis with prominent leptomeningeal enhancement: a subset with a benign outcome. Arthritis Rheum. 2008;58(2): 595–603.CrossRefGoogle ScholarPubMed

Salvarani, C, Brown, RD Jr, Calamia, KT, et al. Angiography-negative primary central nervous system vasculitis: a syndrome involving small cerebral vessels. Medicine. 2008; 87(5): 264–271.CrossRefGoogle ScholarPubMed

Nesher, G, Breuer, GS. Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update. Rambam Maimonides Med J. 2016; 7.CrossRefGoogle ScholarPubMed

Gonzalez-Gay, MA, Vazquez-Rodriguez, TR, Lopez-Diaz, MJ, et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009; 61:1454–1461.CrossRefGoogle ScholarPubMed

Ness, T, Bley, TA, Schmidt, WA, Lamprecht, P. The diagnosis and treatment of giant cell arteritis. Deutsches Arzteblatt Int. 2013; 110:376–385.Google ScholarPubMed

Ness, T, Auw-Hadrich, C, Schmidt, D. [Temporal arteritis (giant cell arteritis). Clinical picture, histology, and treatment]. Ophthalmologe. 2006; 103:296–301.Google ScholarPubMed

Gonzalez-Gay, MA, Lopez-Diaz, MJ, Barros, S. Giant cell arteritis: laboratory tests at the time of diagnosis in a series of 240 patients. Medicine. 2005; 84:277–290.CrossRefGoogle Scholar

Schmidt, WA, Kraft, HE, Vorpahl, K, et al. Color duplex ultrasonography in the diagnosis of temporal arteritis. New Engl J Med. 1997; 337:1336–1342.CrossRefGoogle ScholarPubMed

Bley, TA, Reinhard, M, Hauenstein, C. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum. 2008; 58:2574–2578.CrossRefGoogle ScholarPubMed

Blockmans, D. PET in vasculitis. Ann New York Acad Sci. 2011; 1228:64–70.CrossRefGoogle ScholarPubMed

Poller, DN, van Wyk, Q, Jeffrey, MJ. The importance of skip lesions in temporal arteritis. J Clin Pathol. 2000; 53:137–139.CrossRefGoogle ScholarPubMed

Serling-Boyd, N, Stone, JH. Recent advances in the diagnosis and management of giant cell arteritis. Curr Opin Rheumatol. 2020; 32:201–207.CrossRefGoogle ScholarPubMed

Proven, A, Gabriel, SE, Orces, C, O’Fallon, WM, Hunder, GG. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes. Arthritis Rheum. 2003; 49:703–708.CrossRefGoogle ScholarPubMed

Hellmich, B, Agueda, A, Monti, S, et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020; 79:19–30.CrossRefGoogle ScholarPubMed

Mahr, AD, Jover, JA, Spiera, RF, et al. Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta-analysis. Arthritis Rheum. 2007; 56:2789–2797.CrossRefGoogle ScholarPubMed

Hocevar, A, Jese, R, Rotar, Z, Tomsic, M. Does leflunomide have a role in giant cell arteritis? An open-label study. Clin Rheum. 2019; 38:291–296.CrossRefGoogle ScholarPubMed

Kermani, TA, Warrington, KJ. Prognosis and monitoring of giant cell arteritis and associated complications. Exp Rev Clin Immunol. 2018; 14:379–388.CrossRefGoogle ScholarPubMed

Sailler, L, Paricaud, K. [Giant cell arteritis: Ischemic complications]. Presse Med. 2019; 48:948–955.CrossRefGoogle ScholarPubMed

Pariente, A, Guedon, A, Alamowitch, S, et al. Ischemic stroke in giant-cell arteritis: French retrospective study. J Autoimmun. 2019; 99:48–51.CrossRefGoogle ScholarPubMed

Wilkinson, IM, Russell, RW. Arteries of the head and neck in giant cell arteritis: A pathological study to show the pattern of arterial involvement. Arch Neurol. 1972; 27:378–391.CrossRefGoogle ScholarPubMed

Gonzalez-Gay, MA, Blanco, R, Rodriguez-Valverde, V, et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: Predictors and response to treatment. Arthritis Rheum. 1998; 41:1497–1504.3.0.CO;2-Z>CrossRefGoogle ScholarPubMed

Reich, KA, Giansiracusa, DF, Strongwater, SL. Neurologic manifestations of giant cell arteritis. Am J Med. 1990; 89:67–72.CrossRefGoogle ScholarPubMed

Salvarani, C, Della Bella, C, Cimino, L, et al. Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. Rheumatology (Oxford). 2009; 48:250–253.CrossRefGoogle Scholar

Nesher, G, Berkun, Y, Mates, M, et al. Risk factors for cranial ischemic complications in giant cell arteritis. Medicine. 2004; 83:114–122.CrossRefGoogle ScholarPubMed

de Boysson, H, Liozon, E, Lariviere, D, et al. Giant cell arteritis-related stroke: A retrospective multicenter case-control study. J Rheumatol. 2017; 44:297–303.CrossRefGoogle ScholarPubMed

Samson, M, Jacquin, A, Audia, S, et al. Stroke associated with giant cell arteritis: A population-based study. J Neurol Neurosurg Psychiatry. 2015; 86:216–221.CrossRefGoogle ScholarPubMed

Powers, WJ, Rabinstein, AA, Ackerson, T, et al. Guidelines for the early management of patients with acute ischemic stroke. 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019; 50:e344–e418.CrossRefGoogle Scholar

O’Donnell, MJ, Chin, SL, Rangarajan, S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): A case-control study. Lancet. 2016; 388:761–775.CrossRefGoogle ScholarPubMed

Demarin, V, Rundek, T, Budincevic, H. Kaj je novega v smernicahobravnaveishemičnemožganskekapi/ What is new in the guidelines for ischemic stroke management? In: Žvan, BMZ (Ed.) Akutnamožganskakap. Ljubljana: Društvozapreprečevanjemožganskih in žilnihbolezni. 2015:167–183.Google Scholar

Jennette, JC, Falk, RJ, Bacon, PA, et al. 2012 Revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum. 2013; 65(1):1–11.CrossRefGoogle Scholar

Arend, WP, Michel, BA, Bloch, DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990; 33:1129.CrossRefGoogle ScholarPubMed

Seyahi, E. Takayasu arteritis: An update. Curr Opin Rheumatol. 2017; 29(1):51–56.CrossRefGoogle ScholarPubMed

Ishikawa, K. Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu’s arteriopathy. J Am Coll Cardiol. 1988; 12:964e72.CrossRefGoogle ScholarPubMed

Sharma, BK, Jain, S, Suri, S, Numano, F. Diagnostic criteria for Takayasu arteritis. Int J Cardiol. 1996; 54:S141e7.CrossRefGoogle ScholarPubMed

Serra, R, Butrico, L, Fugetto, F, et al. Updates in pathophysiology, diagnosis and management of Takayasu arteritis. Ann Vasc Surg. 2016; 35:210.CrossRefGoogle ScholarPubMed

Dejaco, C, Ramiro, S, Duftner, C et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018; 77:636–643.CrossRefGoogle ScholarPubMed

Brkic, A, Terslev, L, Møller Døhn, U. Clinical applicability of ultrasound in systemic large vessel vasculitides. Arthritis Rheum. 2019; 71(11):1780–1787.CrossRefGoogle ScholarPubMed

Germanò, G, Monti, S, Ponte, C. The role of ultrasound in the diagnosis and follow-up of large-vessel vasculitis: An update. Clin Exp Rheumatol. 2017; 35 Suppl 103(1):194–198.Google ScholarPubMed

Grayson, PC, Alehashemi, S, Bagheri, AA, et al. 18 F-fluorodeoxyglucose-positron emission tomography as an imaging biomarker in a prospective, longitudinal cohort of patients with large vessel vasculitis. Arthritis Rheum. 2018; 70:439.CrossRefGoogle Scholar

Hellmich, B, Agueda, A, Monti, S. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020; 79(1):19–30.CrossRefGoogle ScholarPubMed

Barut, K, Sahin, S, Kasapcopur, O. Pediatric vasculitis. Curr Opin Rheumatol. 2016;28: 29–38.CrossRefGoogle ScholarPubMed

Sönmez, HE, Armağan, B, Ayan, G, et al. Polyarteritis nodosa: lessons from 25 years of experience. Clin Exp Rheumatol. 2019;37 Suppl 117(2): 52–56.Google ScholarPubMed

Navon Elkan, P, Pierce, SB, Segel, R, et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med. 2014;370(10): 921–931.CrossRefGoogle Scholar

Sahin, S, Adrovic, A, Barut, K, et al. Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency. Rheumatol Int 2018;38(1): 129–136.CrossRefGoogle ScholarPubMed

Sahin, S, Adrovic, A, Kasapcopur, O. A monogenic autoinflammatory disease with fatal vasculitis: deficiency of adenosine deaminase 2. Curr Opin Rheumatol. 2020;32(1): 3–14.CrossRefGoogle ScholarPubMed

Thomson, CC, Tager, AM, Weller, PF. More than your average wheeze. N Engl J Med. 2002;346: 438–442.CrossRefGoogle ScholarPubMed

Masi, AT, Hunder, GG, Lie, JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33: 1094–1100.CrossRefGoogle ScholarPubMed

Sinico, RA, DiToma, L, Maggiore, U, et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg–Strauss syndrome. Arthritis Rheum. 2005;52: 2926–2935.CrossRefGoogle ScholarPubMed

European Vasculitis Genetics Consortium, Lyons, PA, Peters, JE, Alberici, F, et al. Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status. Nat Commun. 2019;10(1): 5120.CrossRefGoogle ScholarPubMed

French Vasculitis Study Group (FVSG), André, R, Cottin, V, Saraux, JL, et al. Central nervous system involvement in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): Report of 26 patients and review of the literature. Autoimmun Rev. 2017;16(9): 963–969.CrossRefGoogle ScholarPubMed

Sarazin, M, Caumes, E, Cohen, A, Amarenco, P. Multiple microembolic border zone brain infarctions and endomyocardial fibrosis in idiopathic hypereosinophilic syndrome and in Schistosoma mansoni infestation. J Neurol Neurosurg Psychiatry. 2004;75(2): 305–307.Google Scholar

Bhagirath, KM, Paulson, K, Ahmadie, R, et al. Clinical utility of cardiac magnetic resonance imaging in Churg-Strauss syndrome: case report and review of the literature. Rheumatol Int. 2009;29(4): 445–449.CrossRefGoogle ScholarPubMed

Ames, PR, Roes, L, Lupoli, S, et al. Thrombosis in Churg-Strauss syndrome: Beyond vasculitis? Br J Rheumatol. 1996;35: 1181–1183.CrossRefGoogle ScholarPubMed

Hira, K, Shimura, H, Kamata, R, et al. Multiple cerebral infarction diagnosed as Eosinophilic Granulomatosis with Polyangiitis by autopsy. BMC Neurol. 2019;19(1): 288.CrossRefGoogle ScholarPubMed

French Vasculitis Study Group (FVSG), Guillevin, L, Pagnoux, C, Seror, R, et al. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vas- culitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore). 2011;90(01): 19–27.CrossRefGoogle Scholar

Barut, K, Sahin, S, Kasapcopur, O. Pediatric vasculitis. Curr Opin Rheumatol. 2016;28: 29–38.CrossRefGoogle ScholarPubMed

De Graeff, N, Groot, N, Brogan, P, et al. European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides – The SHARE initiative. Rheumatology (Oxford). 2019;58: 656–671.CrossRefGoogle ScholarPubMed

Bohm, M, Gonzalez Fernandez, MI, Ozen, S, et al. Clinical features of childhood granulomatosis with polyangiitis (Wegener’s granulomatosis). Pediatr Rheumatol Online J. 2014;12: 18.CrossRefGoogle ScholarPubMed

De Luna, G, Terrier, B, Kaminsky, P, et al. Central nervous system involvement of granulomatosis with polyangiitis: clinical–radiological presentation distinguishes different outcomes. Rheumatology. 2015;54: 424–432.CrossRefGoogle ScholarPubMed

Morishita, K, Li, SC, Muscal, E, et al. Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophilcytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe). J Rheumatol. 2012;39: 1088–1094.Google Scholar

Liebow, AA, Carrington, CR, Friedman, PJ. Lymphomatoid granulomatosis. Hum Pathol. 1972;3(4): 457–558.CrossRefGoogle ScholarPubMed

Dunleavy, K, Roschewski, M, Wilson, WH. Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes. Curr Hematol Malig Rep. 2012;7(3): 208–215.CrossRefGoogle ScholarPubMed

Song, JY, Pittaluga, S, Dunleavy, K, et al. Lymphomatoid granulomatosis – a single institute experience: pathologic findings and clinical correlations. Am J Surg Pathol. 2015;39(2): 141–156.CrossRefGoogle ScholarPubMed

Sukswai, N, Lyapichev, K, Khoury, JD, Medeiros, LJ. Diffuse large B-cell lymphoma variants: an update. Pathology. 2020;52(1): 53–67.CrossRefGoogle ScholarPubMed

Dojcinov, SD, Fend, F, Quintanilla-Martinez, L. EBV-positive lymphoproliferations of B-T-and NK-cell derivation in non-immunocompromised hosts. Pathogens. 2018;7(1): 28.CrossRefGoogle Scholar

Melani, C, Jaffe, ES, Wilson, WH. Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder. Blood. 2020;135(16): 1344–1352.CrossRefGoogle ScholarPubMed

Roschewski, M, Wilson, WH. EBV-associated lymphomas in adults. Best Pract Res Clin Haematol. 2012;25(1): 75–89.CrossRefGoogle ScholarPubMed

Patsalides, AD, Atac, G, Hedge, U, et al. Lymphomatoid granulomatosis: abnormalities of the brain at MR imaging. Radiology. 2005;237(1): 265–273.CrossRefGoogle Scholar

Katzenstein, AL, Doxtader, E, Narendra, S. Lymphomatoid granulomatosis: insights gained over 4 decades. Am J Surgical Pathol. 2010;34(12): e35–e48.CrossRefGoogle ScholarPubMed

Rezk, SA, Weiss, LM. EBV–associated lymphoproliferative disorders: update in classification. Surg Pathol Clin. 2019;12(3): 745–770.CrossRefGoogle ScholarPubMed

Kim, JY, Jung, KC, Park, SH, Choe, JY, Kim, JE. Primary lymphomatoid granulomatosis in the central nervous system: A report of three cases. Neuropathology. 2018;38(4): 331–336.CrossRefGoogle Scholar

Koeller, KK, Shih, RY. Extranodal lymphoma of the central nervous system and spine. Radiol Clin North Am. 2016;54(4): 649–671.CrossRefGoogle ScholarPubMed

Oliveras, C, D’Olhaberriague, L, Garcia, J, Matias-Guiu, X. Parkinsonism as first manifestation of lymphomatoid granulomatosis. J Neurol Neurosurg Psychiatry. 1988;51(7): 999.CrossRefGoogle ScholarPubMed

Borie, R, Wislez, M, Antoine, M, Cadranel, J. Lymphoproliferative disorders of the lung. Respiration. 2017;94(2): 157–175.CrossRefGoogle ScholarPubMed

Tateishi, U, Terae, S, Ogata, A, et al. MR imaging of the brain in lymphomatoid granulomatosis. Am J Neuroradiol. 2001;22(7): 1283–1290.Google ScholarPubMed

Yang, M, Rosenthal, AC, Ashman, JB, Craig, FE. The role and pitfall of F18-FDG PET/CT in surveillance of high grade pulmonary lymphomatoid granulomatosis. Curr Probl Diagn Radiol. 2021;50(3): 443–449.CrossRefGoogle ScholarPubMed

Zhang, YX, Ding, MP, Zhang, T, et al. Lymphomatoid granulomatosis with CNS involvement can lead to spontaneous remission: case study. CNS Neurosci Ther. 2013;19(7): 536.CrossRefGoogle ScholarPubMed

Aiko, N, Sekine, A, Umeda, S, et al. The spontaneous regression of grade 3 methotrexate-related lymphomatoid granulomatosis: a case report and literature review. Intern Med. 2018;57(21): 3163–3167.CrossRefGoogle ScholarPubMed

Tang, VK, Vijhani, P, Cherian, SV, et al. Primary pulmonary lymphoproliferative neoplasms. Lung India. 2018;35(3): 220–230.Google ScholarPubMed

Katzenstein, AL, Carrington, CB, Liebow, AA: Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases. Cancer. 1979;43: 360–373.3.0.CO;2-8>CrossRefGoogle ScholarPubMed

Dörr, J, Krautwald, S, Wildemann, B, et al. Characteristics of Susac syndrome: a review of all reported cases. Nat Rev Neurol. 2013;9(6): 307–316.CrossRefGoogle ScholarPubMed

Karahan, SZ, Boz, C, Saip, S, et al. Susac syndrome: clinical characteristics, diagnostic findings and treatment in 19 cases. Mult Scler Relat Disord. 2019;33: 94–99.CrossRefGoogle Scholar

García-Carrasco, M, Jiménez-Hernández, C, Jiménez-Hernández, M, et al. Susac’s syndrome: an update. Autoimmun Rev. 2011;10(9): 548–552.CrossRefGoogle ScholarPubMed

Mateen, FJ, Zubkoc, AY, Muralidharan, R, et al. Susac syndrome: clinical characteristics and treatment in 29 new cases. Eur J Neurol. 2012;19(6): 800–811.CrossRefGoogle ScholarPubMed

Vodopivec, I, Venna, N, Rizzo, JF, Prasad, S. Clinical features, diagnostic findings, and treatment of Susac syndrome: a case series. J Neurol Sci. 2015;357(1–2): 50–57.CrossRefGoogle ScholarPubMed

European Susac Consortium (EuSaC), Kleffner, I, Dörr, J, Ringelstein, M, et al. Diagnostic criteria for Susac syndrome. J Neurol Neurosurg Psychiatry. 2016;87(12): 1287–1295.CrossRefGoogle ScholarPubMed

Susac, JO1, Murtagh, FR, Egan, RA, et al. MRI findings in Susac’s syndrome. Neurology. 2003; 61(12): 1783–1787.CrossRefGoogle ScholarPubMed

Fox, RJ, Costello, F, Judkins, AR, et al. Treatment of Susac syndrome with gamma globulin and corticosteroids. J Neurol Sci. 2006;251: 17–22.CrossRefGoogle ScholarPubMed

Vishnevskia-Dai, V, Chapman, J, Sheinfeld, R, et al. Susac syndrome: clinical characteristics, clinical classification, and long-term prognosis. Medicine. 2016;95(43): e5223.CrossRefGoogle ScholarPubMed

Shruthi, P, Sridhar, A, Sharath Kumar, G. Case of the week: Vogt-Koyanagi-Harada syndrome (VKH). Am J Neuroradiol. 2018. www.ajnr.org/content/cow/12062018 (accessed January 2022).Google Scholar

Yang, P, Ren, Y, Li, B, et al. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology. 2007;114: 606–614.CrossRefGoogle ScholarPubMed

Lavezzo, MM, Sakata, VM, Morita, C, et al. Vogt-Koyanagi-Harada disease: Review of a rare autoimmune disease targeting antigens of melanocytes. Orphanet J Rare Dis. 2016;11: 29.CrossRefGoogle ScholarPubMed

Patil, YB, Garg, R, Rajguru, JP, et al. Vogt-Koyanagi-Harada (VKH) syndrome: A new perspective for healthcare professionals. J Family Med Prim Care. 2020;9: 31–35.Google ScholarPubMed

Yang, P, Zhong, Y, Du, L, et al. Development and evaluation of diagnostic criteria for Vogt-Koyanagi-Harada disease. JAMA Ophthalmol. 2018;136: 1025–1031.CrossRefGoogle ScholarPubMed

Azad, SV, Takkar, B, Venkatesh, P. Eye and Vasculitis. J Vasc. 2016;2: 108.CrossRefGoogle Scholar

Crawford, CM. Primary Retinal Vasculitis Vs Eales’ Disease. Int J Open Access Opthalmology. 2016;1(3): 1–8.Google Scholar

Rosenbaum, JT, Sibley, CH, Lin, P. Retinal Vasculitis. Curr Opin Rheumatol. 2016;28(3): 228–235.CrossRefGoogle ScholarPubMed

Das, T, Pathengay, A, Hussain, N, Biswas, J. Eales’ disease: diagnosis and management. Eye (Lond). 2010;24(3): 472–482.CrossRefGoogle ScholarPubMed

Biswas, J, Raghavendran, R, Pinakin, G, Arjundas, D. Presumed Eales’ disease with neurologic involvement: Report of three cases. Retina. 2001;21(2): 141–145.CrossRefGoogle ScholarPubMed

Gordon, MF, Coyle, PK, Golub, B. Eales’ disease presenting as stroke in the young adult. Ann Neurol. 1988;24(2): 264–266.Google Scholar

Biswas, J, Ravi, RK, Naryanasamy, A, Kulandai, LT, Madhavan, HN. Eales’ disease – current concepts in diagnosis and management. J Ophthalmic Inflamm Infect. 2013;3: 11.CrossRefGoogle ScholarPubMed

Cogan, DG. Syndrome of nonsyphilitic interstitial keratitis and vestibuloauditory symptoms. Arch Ophthalmol. 1945;33: 144–149.CrossRefGoogle Scholar

Pagnini, I, Zannin, ME, Vittadello, F, et al. Clinical features and outcome of Cogan syndrome. J Pediatr. 2012;160: 303–307.CrossRefGoogle ScholarPubMed

Haynes, BF, Kaiser-Kupfer, MI, Mason, P, Fauci, AS. Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine (Baltimore). 1980;59: 426–441.Google Scholar

Bonaguri, C, Orsoni, J, Russo, A, et al. Mora P Cogan’s syndrome: Anti-Hsp70 antibodies are a serological marker in the typical form. Isr Med Assoc J. 2014;16: 285–288.Google ScholarPubMed

Gluth, MB, Baratz, KH, Matteson, EL, Driscoll, CL. Cogan syndrome: a retrospective review of 60 patients throughout a half-century. Mayo Clin Proc. 2006;81: 483–488.CrossRefGoogle ScholarPubMed

Antonios, N, Silliman, S. Cogan syndrome: an analysis of reported neurological manifestations. Neurologist. 2012;18: 55–63.CrossRefGoogle ScholarPubMed

Casselman, JW, Majoor, MH, Albers, FW. MR of the inner ear in patients with Cogan syndrome. Am J Neuroradiol. 1994;15: 131–138.Google ScholarPubMed

Study Group for Cogan’s Syndrome, Grasland, A, Pouchot, J, Hachulla, E, et al. Typical and atypical Cogan’s syndrome: 32 cases and review of the literature.Rheumatology (Oxford). 2004;438: 1007–1015.CrossRefGoogle Scholar

Daniel, JW, Dafna, DG. Clinical manifestations and diagnosis of systemic lupus erythematosus in adults. www.uptodate.com. Literature review current through: Mar 2020.Last updated: Dec.10,2019. (accessed January 2022).Google Scholar

Schur, PH. Neurologic manifestation of systemic lupus erythematosus in adults. www.uptodate.com. Literature review current through: Mar 2020.Last updated: Feb 21, 2019. (accessed January 2022).Google Scholar

Cooper, GS, Dooley, MA, Treadwell, EL, et al. Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. Arthritis Rheum. 1998;41(10): 1714–1724.3.0.CO;2-U>CrossRefGoogle ScholarPubMed

The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42: 599.Google Scholar

Hanly, JG, Kozora, E, Beyea, SD, Birnbaum, J. Review: Nervous system disease in systemic lupus erythematosus. Current status and future directions. Arthritis Rheumatol. 2019;71: 33.CrossRefGoogle ScholarPubMed

Saadatnia, M, Sayed-Bonakdar, Z, Mohammad-Sharifi, G, Sarrami, AH. The necessity of stroke prevention in patients with systemic lupus erythematosus. J Res Med Sci. 2012;17: 894–895.Google ScholarPubMed

Holmqvist, M, Simard, JF, Asplund, K, Arkema, EV. Stroke in systemic lupus erythematosus: A meta-analysis of population-based cohort studies. RMD Open 2015;1: e000168.CrossRefGoogle ScholarPubMed

Duman, T, Demirci, S, Uluduz, D et al. Cerebral venous sinus thrombosis as a rare complication of systemic lupus erythematosus: subgroup analysis of the VENOST study. J Stroke Cerebrovasc Dis. 2019;28(12): 104372.Google Scholar

Rowshani, AT, Remans, P, Rozemuller, A, Tak, PP. Cerebral vasculitis as a primary manifestation of systemic lupus erythematosus. Ann Rheum Dis. 2005;64: 784–786.CrossRefGoogle ScholarPubMed

Pomper, MG, Miller, TJ, Stone, JH, et al. CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography. Am J Neuroradiol. 1999;20: 75–85.Google Scholar

Kantarci, O. Neuro-Behçet’s syndrome. In: Mayo Clinic Neurology Grand Rounds. Rochester: Mayo Clinic; 2018.Google Scholar

Kocer, N, Islak, C, Siva, A, et al. CNS involvement in Neuro-Behcet’s syndrome: an MR study. Am J Neuroradiol. 1999;20: 1015–1024.Google Scholar

Siva, A, Kantarci, OH, Saip, S, et al. Behçet’s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol. 2001;248: 95–103.Google Scholar

Siva, A, Saip, S. The spectrum of nervous system involvement in Behçet’s syndrome and its differential diagnosis. J Neurol. 2009;256(4): 513–529.CrossRefGoogle ScholarPubMed

Uygunoglu, U, Zeydan, B, Ozguler, Y, et al. Myelopathy in Behçet’s disease: the Bagel Sign. Ann Neurol. 2017;82(2): 288–298.CrossRefGoogle ScholarPubMed

Uygunoğlu, U, Siva, A. Behçet’s syndrome and nervous system involvement. Curr Neurol Neurosci Rep. 2018;18(7): 35.CrossRefGoogle ScholarPubMed

Uygunoglu, U, Siva, A. Behçet syndrome and the nervous system. In: Yazici, Y, Hatemi, G, Seyahi, E, Yazici, H (Eds), Behçet Syndrome. Springer: Cham; 2020, 73–82.Google Scholar

Zeydan, B, Uygunoglu, U, Saip, S, et al. Infliximab is a plausible alternative for neurologic complications of Behçet disease. Neurol Neuroimmunol Neuroinflamm. 2016;3(5): e258.CrossRefGoogle ScholarPubMed

Bournia, VK, Vlachoyiannopoulos, PG. Subgroups of Sjögren syndrome patients according to serological profiles. J Autoimmun. 2012;39: 15–26.CrossRefGoogle ScholarPubMed

Berkowitz, AL, Samuels, MA. The neurology of Sjögren’s syndrome and the rheumatology of peripheral neuropathy and myelitis. Pract Neurol. 2014;14(1): 14–22.CrossRefGoogle ScholarPubMed

Yong, WC, Sanguankeo, A, Upala, S, et al. Association between primary Sjögren’s syndrome, arterial stiffness, and subclinical atherosclerosis: a systematic review and meta-analysis. Clin Rheumatol. 2019;38: 447–455.CrossRefGoogle ScholarPubMed

Valim, V, Gerdts, E, Jonsson, R, et al. Atherosclerosis in Sjögren’s syndrome: evidence, possible mechanisms and knowledge gaps. Clin Exp Rheumatol. 2016;34(1): 133–142.Google ScholarPubMed

Vitali, C, Bombardieri, S, Jonsson, R, et al. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61: 554–558.Google Scholar

Ramos-Casals, M, Tzioufas, AG, Stone, JH, Sisó, A, Bosch, X. Treatment of primary Sjögren syndrome a systematic review. J Am Med Assoc. 2010;304: 452–460.CrossRefGoogle ScholarPubMed

Seror, R, Sordet, C, Guillevin, L, et al.Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren’s syndrome. Ann Rheum Dis. 2007;66(3): 351–357.CrossRefGoogle ScholarPubMed

Pers, JO, Devauchelle, V, Daridon, C, et al. BAFF-modulated repopulation of B lymphocytes in the blood and salivary glands of rituximab-treated patients with Sjögren’s syndrome. Arthritis Rheum. 2007;56(5): 1464–1477.CrossRefGoogle ScholarPubMed

Iannuzzi, MC, Fontana, JR. Sarcoidosis: Clinical presentation, immunopathogenesis, and therapeutics. J Am Med Assoc. 2011;305(4): 391–399.CrossRefGoogle ScholarPubMed

Degardin, A, Devos, P, Vermersch, P, de Seze, J. Cerebrovascular symptomatic involvement in sarcoidosis. Acta Neurol Belg. 2010;110(4): 349–352.Google ScholarPubMed

Ungprasert, P, Matteson, EL. Neurosarcoidosis. Rheum Dis Clin North Am. 2017;43(4): 593–606.CrossRefGoogle ScholarPubMed

Bathla, G, Watal, P, Gupta, S, et al. Cerebrovascular manifestations of neurosarcoidosis: an underrecognized aspect of the imaging spectrum. Am J Neuroradiol. 2018;39(7): 1194–1200.CrossRefGoogle ScholarPubMed

Voortman, M, Drent, M, Baughman, RP. Management of neurosarcoidosis: a clinical challenge. Curr Opin Neurol. 2019;32(3): 475–483.CrossRefGoogle ScholarPubMed

Sy, A, Khalidi, N, Dehghan, N, et al. Vasculitis in patients with inflammatory bowel diseases: A study of 32 patients and systematic review of the literature. Semin Arthritis Rheum. 2016;45(4): 475–482.Google Scholar

Kilic, L, Kalyoncu, U, Karadag, O, et al. Inflammatory bowel diseases and Takayasu’s arteritis: coincidence or association? Int J Rheum Dis. 2016;19(8): 814–818.Google Scholar

Akiyama, S, Fujii, T, Matsuoka, K, et al. Endoscopic features and genetic background of inflammatory bowel disease complicated with Takayasu arteritis. J Gastroenterol Hepatol. 2017;32(5): 1011–1017.CrossRefGoogle ScholarPubMed

Anderson, E, Gakhar, N, Stull, C, Caplan, L. Gastrointestinal and Hepatic Disease in Vasculitis. Rheum Dis Clin North Am. 2018;44(1): 1–14.Google Scholar

Hatemi, I, Hatemi, G, Çelik, AF. Systemic vasculitis and the gut. Curr Opin Rheumatol. 2017;29(1): 33–38.CrossRefGoogle ScholarPubMed

Auriel, E, Charidimou, A, Gurol, E. Validation of clinic-radiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation. JAMA Neurol. 2016;73: 197.CrossRefGoogle Scholar

Greenberg, SM, Bacskai, BJ, Hernandez-Guillamon, M. Cerebral amyloid angiopathy and Alzheimer disease – one peptide, two pathways. Nat Rev Neurol. 2020;16: 30–42.CrossRefGoogle ScholarPubMed

DiFrancesco, JC, Brioschi, M, Brighina, L, Ruffmann, C, Saracchi, E. Anti-A autoantibodies in the CSF of a patient with CAA-related inflammation: A case report. Neurology. 2011;76: 842–844.CrossRefGoogle Scholar

DiFrancesco, C, Touat, M, Caulo, M, Gallucci, M. Recurrence of cerebral amyloid angiopathy-related inflammation: A report of two cases from the ICAβ International Network. J Alzheimers Dis. 2015;46: 1071–1077.Google Scholar

Kinnecom, C, Lev, MH, Wendell, L, Smith, EE. Course of cerebral amyloid angiopathy-related inflammation. Neurology. 2004;68: 1411–1416.Google Scholar

Berkowitz, AL, Baker, JM, Miller, JJ, Greenberg, SM. Mystery case: Cerebral amyloid angiopathy-related inflammation. Neurology. 2014;83: 1678–1679.CrossRefGoogle ScholarPubMed

Chung, KK, Anderson, NE, Hutchinson, D. Cerebral amyloid angiopathy related inflammation: Three case reports and a review. J Neurol Neurosurg Psychiatry. 2011;82: 20–26.Google Scholar

Corovic, A, Kelly, S, Markus, S. Cerebral amyloid angiopathy associated with inflammation: A systematic review of clinical and imaging features and outcome. Int J Stroke 2018;13(3): 257–267.CrossRefGoogle ScholarPubMed

Kang, P, Bucelli, RC, Ferguson, CJ. Teaching neuroimages: cerebral amyloid angiopathy-related inflammation presenting with isolated leptomeningitis. Neurology. 2017;9: e66–e67.Google Scholar

Liang, JW, Zhang, W, Sarlin, J. Case of cerebral amyloid angiopathy-related inflammation – is the absence of cerebral microbleeds a good prognostic sign? J Stroke Cerebrovasc Dis. 2015;4: e319–e322.Google Scholar

Renard, D, Wacongne, A, Thouvenot, E. Radiologically isolated cerebral amyloid angiopathy-related inflammation. J Stroke Cerebrovasc Dis. 2017;6: e218–e220.CrossRefGoogle Scholar

Banerjee, G, Alvares, D, Bowen, J. Minimally symptomatic cerebral amyloid angiopathy-related inflammation: three descriptive case reports. J Neurol Neurosurg Psychiatr. 2019;90: 113–115.CrossRefGoogle ScholarPubMed

Sperling, RA, Jack, CR Jr, Black, SE. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup. Alzheimers Dement. 2011;7: 367–85.CrossRefGoogle ScholarPubMed

Ketter, N, Brashear, HR, Bogert, J. Central review of amyloid-related imaging abnormalities in two phase iii clinical trials of bapineuzumab in mild-to-moderate Alzheimer’s disease patients. J Alzheimers Dis. 2017;57(2): 557–573.CrossRefGoogle ScholarPubMed

Barakos, J, Sperling, R, Salloway, S, Imaging, MR Features of Amyloid-Related Imaging Abnormalities. Am J Neuroradiol. 2013;34: 1958–1965.CrossRefGoogle ScholarPubMed

Arrighi, HM, Barakos, J, Barkhof, F, Tampieri, D. Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer’s disease treated with bapineuzumab: a historical, prospective secondary analysis. J Neurol Neurosurg Psychiatry. 2016;87: 106–112.Google ScholarPubMed

Piazza, F, Greenberg, SM, Savoiardo, M. Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol. 2013;73: 449–458.CrossRefGoogle ScholarPubMed

Linn, J, Halpin, A, Demaerel, P, et al. Prevalence of superficial siderosis in patients with cerebral amyloid angiopathy. Neurology. 2010;74(17): 1346–1350.CrossRefGoogle ScholarPubMed

Wollenweber, FA, Baykara, E, Zedde, M, Gesierich, B. Cortical superficial siderosis in different types of cerebral small vessel disease. Stroke. 2017;48(5): 1404–1407.Google Scholar

Wollenweber, FA, Opherk, C, Zedde, M, Catak, C. Prognostic relevance of cortical superficial siderosis in cerebral amyloid angiopathy. Neurology. 2019;92(8): e792–e801.CrossRefGoogle ScholarPubMed

Salvarani, C, Hunder, GG, Morris, JM. Aβ-related angiitis comparison with CAA without inflammation and primary CNS vasculitis. Neurology. 2013;81(18): 1596–1603.CrossRefGoogle ScholarPubMed

DiFrancesco, JC, Longoni, M Piazza, F. Anti-Aβ autoantibodies in amyloid related imaging abnormalities (ARIA): Candidate biomarker for immunotherapy in Alzheimer’s disease and cerebral amyloid angiopathy. Front Neurol. 6: 207.Google Scholar

Regenhardt, RW, Thon, JM, Das, AS. Association between immunosuppressive treatment and outcomes of cerebral amyloid angiopathy-related inflammation. JAMA Neurol. 2020;22: e201782.Google Scholar

Catak, C, Zedde, M, Malik, R, Janowitz, D, Soric, V. Decreased CSF levels of β-amyloid in patients with cortical superficial siderosis. Front Neurol. 2019;10: 439.Google Scholar

Piazza, F, Winblad, B. Amyloid-Related Imaging Abnormalities (ARIA) in immunotherapy trials for Alzheimer’s disease: Need for prognostic biomarkers? J Alzheimers Dis. 2016;52(2): 417–420.CrossRefGoogle ScholarPubMed

Carmona-Iragui, M, Fernández-Arcos, A, Alcolea, D. Cerebrospinal fluid anti-amyloid-β autoantibodies and amyloid PET in cerebral amyloid angiopathy-related inflammation. J Alzheimers Dis. 2016;50(1): 1–7.CrossRefGoogle ScholarPubMed

Xu, YY, Chen, S, Zhao, JH, Chen, XL. A case of cerebral amyloid angiopathy-related inflammation with the rare apolipoprotein +2/+2 genotype. Front Neurol. 10: 547.CrossRefGoogle Scholar

Nelson, PT, Pious, NM, Jicha, GA, Wilcock, DM. APOE-+2 and APOE-+4 correlate with increased amyloid accumulation in cerebral vasculature. J Neuropathol Exp Neurol. 2013;2: 708–715.Google Scholar

Marini, S, Crawford, K, Morotti, A, Lee, MJ. Association of apolipoprotein e with intracerebral hemorrhage risk by race/ethnicity: A meta-analysis. JAMA Neurol. 2019;76(4): 480–491.Google Scholar